Ware RE - Search Results

1

Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.

Kalff V, Hicks RJ, MacManus MP, Binns DS, McKenzie AF, Ware RE, Hogg A, Ball DL. Kalff V, et al. Among authors: ware re. J Clin Oncol. 2001 Jan 1;19(1):111-8. doi: 10.1200/JCO.2001.19.1.111. J Clin Oncol. 2001. PMID: 11134203

2

Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner.

Hicks RJ, Binns DS, Fawcett ME, Ware RE, Kalff V, McKenzie AF, Zalcberg JP, Peters LJ. Hicks RJ, et al. Among authors: ware re. Med J Aust. 1999 Nov 15;171(10):529-32. doi: 10.5694/j.1326-5377.1999.tb123787.x. Med J Aust. 1999. PMID: 10816703

3

29. F-18 FDG PET for Suspected or Confirmed Regional Recurrence of Colon Cancer. A Prospective Study of Impact and Outcome.

Kalff V V, Hicks R, Ware R, Binns D, McKenzie A. Kalff V V, et al. Clin Positron Imaging. 2000 Jul;3(4):183. doi: 10.1016/s1095-0397(00)00095-9. Clin Positron Imaging. 2000. PMID: 11150786

4

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL. MacManus MP, et al. Among authors: ware re. Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):287-93. doi: 10.1016/s0360-3016(01)01477-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11380213 Clinical Trial.

5

The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal--based PET scanner in the presurgical evaluation of partial epilepsy.

O'Brien TJ, Hicks RJ, Ware R, Binns DS, Murphy M, Cook MJ. O'Brien TJ, et al. J Nucl Med. 2001 Aug;42(8):1158-65. J Nucl Med. 2001. PMID: 11483674 Free article. Clinical Trial.

6

Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible.

Pitman AG, Hicks RJ, Kalff V, Binns DS, Ware RE, McKenzie AF, Ball DL, MacManus MP. Pitman AG, et al. Among authors: ware re. Med J Aust. 2001 Sep 17;175(6):303-7. doi: 10.5694/j.1326-5377.2001.tb143587.x. Med J Aust. 2001. PMID: 11665943

7

(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.

Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. Among authors: ware re. J Nucl Med. 2001 Nov;42(11):1596-604. J Nucl Med. 2001. PMID: 11696627 Free article. Clinical Trial.

8

The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.

Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. Among authors: ware re. J Nucl Med. 2001 Nov;42(11):1605-13. J Nucl Med. 2001. PMID: 11696628 Free article. Clinical Trial.

9

Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.

Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M. Wirth A, et al. Am J Med. 2002 Mar;112(4):262-8. doi: 10.1016/s0002-9343(01)01117-2. Am J Med. 2002. PMID: 11893364

10

Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.

Pitman AG, Hicks RJ, Binns DS, Ware RE, Kalff V, McKenzie AF, Ball DL, MacManus MP. Pitman AG, et al. Among authors: ware re. Br J Radiol. 2002 Feb;75(890):114-21. doi: 10.1259/bjr.75.890.750114. Br J Radiol. 2002. PMID: 11893634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters